At least 11 new breakthrough therapy designations have been announced in the first seven weeks of 2016, as the expedited review program's popularity continues to rise at a fast pace.
Breakthrough Pace Shows No Signs Of Slowing
FDA started off 2016 with a spate of new breakthrough therapy designations, feeding the popular program – and fueling agency concerns about workforce strain.